Osceola Capital-Backed Revelation Pharma Acquires Everwell Specialty Pharmacy
March 23, 2021
Osceola Capital formed Revelation Pharma Corp as a pharmacy compounding platform in partnership with industry veteran Jacob Beckel and concurrently completed the acquisition of Pensacola-based Everwell Specialty Pharmacy. Revelation will pursue consolidation of 503A compounding pharmacies nationally, with Everwell serving as the initial platform asset focused on anti-infectives, specialty compounding and other therapeutic classes.
- Targets
- Everwell Specialty Pharmacy
- Platforms
- Revelation Pharma Corp
- Industry
- Healthcare Services
- Location
- Florida, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.